SG Americas Securities LLC Boosts Stake in Cellebrite DI Ltd. (NASDAQ:CLBT)

SG Americas Securities LLC raised its position in Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) by 2,244.2% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 209,529 shares of the company's stock after purchasing an additional 200,591 shares during the period. SG Americas Securities LLC owned 0.10% of Cellebrite DI worth $4,616,000 at the end of the most recent reporting period.

A number of other institutional investors have also added to or reduced their stakes in CLBT. Quarry LP purchased a new stake in shares of Cellebrite DI in the 3rd quarter worth about $27,000. Point72 Asia Singapore Pte. Ltd. grew its holdings in shares of Cellebrite DI by 59.6% during the second quarter. Point72 Asia Singapore Pte. Ltd. now owns 2,724 shares of the company's stock valued at $33,000 after buying an additional 1,017 shares during the last quarter. Advisors Asset Management Inc. boosted its position in shares of Cellebrite DI by 130.5% during the third quarter. Advisors Asset Management Inc. now owns 3,077 shares of the company's stock valued at $52,000 after buying an additional 1,742 shares during the last quarter. Public Employees Retirement Association of Colorado purchased a new stake in Cellebrite DI during the 2nd quarter valued at $71,000. Finally, Pathway Financial Advisers LLC grew its position in Cellebrite DI by 1,583.8% during the third quarter. Pathway Financial Advisers LLC now owns 4,378 shares of the company's stock valued at $74,000 after buying an additional 4,118 shares during the period. 45.88% of the stock is currently owned by institutional investors.

Cellebrite DI Stock Performance

Shares of CLBT stock traded up $0.28 on Friday, reaching $23.70. 1,482,001 shares of the company were exchanged, compared to its average volume of 1,062,381. The business has a 50-day moving average price of $21.29 and a 200 day moving average price of $18.00. The company has a market cap of $4.88 billion, a price-to-earnings ratio of -15.29, a P/E/G ratio of 3.52 and a beta of 1.46. Cellebrite DI Ltd. has a 1 year low of $8.73 and a 1 year high of $24.18.

Cellebrite DI (NASDAQ:CLBT - Get Free Report) last posted its quarterly earnings results on Wednesday, November 6th. The company reported $0.14 EPS for the quarter, topping the consensus estimate of $0.09 by $0.05. Cellebrite DI had a negative net margin of 82.28% and a positive return on equity of 122.59%. The business had revenue of $106.90 million during the quarter, compared to the consensus estimate of $102.06 million. During the same quarter in the previous year, the firm posted $0.09 earnings per share. The company's quarterly revenue was up 27.0% compared to the same quarter last year. As a group, equities analysts anticipate that Cellebrite DI Ltd. will post 0.32 earnings per share for the current year.

Wall Street Analysts Forecast Growth

CLBT has been the subject of a number of analyst reports. Needham & Company LLC increased their price target on Cellebrite DI from $21.00 to $28.00 and gave the stock a "buy" rating in a research note on Wednesday. Craig Hallum lifted their target price on Cellebrite DI from $23.00 to $24.00 and gave the company a "buy" rating in a research note on Thursday, November 7th. Finally, JPMorgan Chase & Co. increased their price objective on shares of Cellebrite DI from $22.00 to $24.00 and gave the company an "overweight" rating in a report on Monday, December 16th. Eight equities research analysts have rated the stock with a buy rating, According to MarketBeat.com, the company presently has a consensus rating of "Buy" and a consensus target price of $21.57.

Cellebrite DI Profile

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft.